Form D - Notice of Exempt Offering of Securities:
SEC Accession No. 0001673510-17-000002
Filing Date
2017-09-25
Accepted
2017-09-25 14:42:43
Documents
1
Effectiveness Date
2017-09-25
Items
Item 06b:

Document Format Files

Seq Description Document Type Size
1 primary_doc.html D  
1 primary_doc.xml D 12936
  Complete submission text file 0001673510-17-000002.txt   14100
Mailing Address 15 INDEPENDENCE BOULEVARD 4TH FLOOR WARREN NJ 07059
Business Address 15 INDEPENDENCE BOULEVARD 4TH FLOOR WARREN NJ 07059 617 431 3600
Alcresta Therapeutics, Inc. (Filer) CIK: 0001673510 (see all company filings)

EIN.: 452729951 | State of Incorp.: DE | Fiscal Year End: 1231
Type: D | Act: 33 | File No.: 021-295327 | Film No.: 171099559